PW 4153

Drug Profile

PW 4153

Alternative Names: Levodopa/carbidopa extended-release - Penwest; PW-4153

Latest Information Update: 11 Nov 2008

Price : $50

At a glance

  • Originator Penwest Pharmaceuticals
  • Class Antiparkinsonians; Aromatic amino acids; Catecholamines; Hydrazines; Small molecules
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Parkinson's disease

Most Recent Events

  • 04 Nov 2008 Discontinued - Phase-I for Parkinson's disease in USA (PO)
  • 21 Jul 2008 Phase-I clinical trials in Parkinson's disease in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top